Showing results (1-10 of 343) with videos related to
Sort By:
Pageof 35
European Heart Journal Supplements : Journal of the European Society of Cardiology|March 7, 2019
Hyperkalaemia: aetiology, epidemiology, and clinical significanceJasper Tromp, Peter van der MeerNature Reviews. Cardiology|June 29, 2011
Acute coronary syndromes: the unfulfilled promise of erythropoietin in patients with MIPeter van der Meer, Dirk J van VeldhuisenEuropean Journal of Heart Failure|March 26, 2011
Heart failure highlights in 2010Kevin Damman, Alexander H Maass, Peter van der MeerStem Cells Translational Medicine|October 11, 2018
Concise Review: The Current State of Human In Vitro Cardiac Disease Modeling: A Focus on Gene Editing and Tissue EngineeringMartijn F Hoes, Nils Bomer, Peter van der MeerExpert Opinion on Investigational Drugs|May 14, 2013
The potential role of valsartan + AHU377 ( LCZ696 ) in the treatment of heart failureAdriaan A Voors, Bernard Dorhout, Peter van der MeerNederlands Tijdschrift Voor Geneeskunde|April 20, 2023
[Cardiomyopathy due to a mutation in the phospholamban gene: a high-impact genetic abnormality]Peter van der Meer, Eva van Rooij, Pieter A DoevendansCurrent Heart Failure Reports|April 9, 2021
Selenium, Selenoproteins, and Heart Failure: Current Knowledge and Future PerspectiveAli A Al-Mubarak, Peter van der Meer, Nils BomerCardiovascular Therapeutics|October 27, 2010
Erythropoiesis-stimulating agents and heart failureErik Lipšic, Peter van der Meer, Dirk J van VeldhuisenJournal of the American College of Cardiology|June 1, 2019
ACC/AHA Versus ESC Guidelines on Heart Failure: JACC Guideline ComparisonPeter van der Meer, Hanna K Gaggin, G William DecClinical Science (London, England : 1979)|November 15, 2007
Erythropoietin in cardiovascular diseases: exploring new avenuesPeter van der Meer, Dirk J van Veldhuisen, James L JanuzziPageof 35